Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) traded down 2% during trading on Tuesday . The company traded as low as $0.3350 and last traded at $0.3382. 187,031 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $0.3450.
BioRestorative Therapies Stock Performance
The firm has a market cap of $557.47 million, a price-to-earnings ratio of -0.32 and a beta of 102.36. The stock’s 50 day simple moving average is $0.33 and its 200-day simple moving average is $0.49.
About BioRestorative Therapies
BioRestorative Therapies, Inc is a clinical‐stage regenerative medicine company focused on developing and commercializing advanced therapeutic platforms to promote tissue repair and healing. The company’s principal business activities are conducted through its wholly owned subsidiary, TissueForm, Inc, which holds the rights to a proprietary micro‐fiber scaffold technology designed to create a three‐dimensional matrix supporting cell migration, proliferation and new tissue formation. BioRestorative’s work is primarily targeted at chronic and non‐healing wounds, including diabetic foot ulcers and other complex soft‐tissue injuries.
The cornerstone of BioRestorative’s product pipeline is the TissueForm® line of scaffold materials.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
-ltd-logo-1200x675.png){kind=logo}
